Basic Information
RNALocate ID: | RLID:11002015 |
RNA Symbol: | hsa-miR-320a-3p |
Localization: | Microvesicle |
RNA Information
RNA Name: | hsa-miR-320a |
RNA ID: | miRBase:MIMAT0000510 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 23539611 |
Tissue/Cell Line: | Seminal plasma |
Method: | Microarray |
Description: | In order to assess the reversibility of post-vasectomy miRNA sequelae, we investigated whether SMV miRNAs altered by vasectomy could be retrieved in SMVs from normospermic vasovasostomized donors. miRNA microarray profiling performed on SMVs from normal, vasectomized and vasovasostomized donors identified 313 miRNAs whose intensity was above the threshold of detection. Among these miRNAs, 293 were detected in samples from normal donors, 275 in vasectomized donors and 298 in vasovasostomized donors (Fig. 3, Supplementary data, Table SIV). Data are collected from Table S4. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001858 | Cytoplasm | Cardiomyocytes | 31837603 |
RLID:01001859 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001860 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001861 | Mitochondrion | HEK-293 cells|HeLa cells | 27396686 |
RLID:01001862 | Mitochondrion | HEK-293 cells|HeLa cells | 27563705 |
RLID:01001863 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001864 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001865 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001866 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001867 | Nucleus | Cardiomyocytes | 31837603 |
RLID:01001868 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001869 | Nucleus | Neural progenitor cells | 21363885 |
RLID:11001998 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
RLID:11001999 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
RLID:11002000 | Exosome | Pooled sera | 27278097 |
RLID:11002001 | Exosome | Serum | 18589210 |
RLID:11002002 | Exosome | Glioblastoma cells | 19011622 |
RLID:11002003 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11002004 | Exosome | Ovarian follicular fluid | 22116803 |
RLID:11002005 | Exosome | Brain tissue | 23382797 |
RLID:11002006 | Exosome | Plasma | 23663360 |
RLID:11002007 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11002008 | Exosome | Serum | 25135963 |
RLID:11002009 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11002010 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
RLID:11002011 | Exosome | Cerebrospinal fluid | 25420022 |
RLID:11002012 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11002013 | Microvesicle | Glioblastoma cells | 19011622 |
RLID:11002014 | Microvesicle | Plasma | 23077538 |
RLID:11002016 | Microvesicle | Follicular fluid | 23666971 |
RLID:11002017 | Microvesicle | Serum | 24797360 |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-320a-3p | Cardiomyopathy | MNDR-E-MI-39294 |
MNDR | hsa-miR-320a-3p | Diffuse large b cell lymphoma | MNDR-E-MI-39295 |
MNDR | hsa-miR-320a-3p | Splenic marginal zone lymphoma | MNDR-E-MI-39296 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-39297 |
MNDR | hsa-miR-320a-3p | Follicular lymphoma | MNDR-E-MI-39298 |
MNDR | hsa-miR-320a-3p | Medulloblastoma | MNDR-E-MI-39299 |
MNDR | hsa-miR-320a-3p | Lymphoma | MNDR-E-MI-39300 |
MNDR | hsa-miR-320a-3p | Estrogen-receptor positive breast cancer | MNDR-E-MI-39301 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor positive breast cancer | MNDR-E-MI-39302 |
MNDR | hsa-miR-320a-3p | Progesterone-receptor negative breast cancer | MNDR-E-MI-39303 |
MNDR | hsa-miR-320a-3p | Breast cancer luminal | MNDR-E-MI-39304 |
MNDR | hsa-miR-320a-3p | Lupus nephritis | MNDR-E-MI-39305 |
MNDR | hsa-miR-320a-3p | Prostate cancer | MNDR-E-MI-39306 |
MNDR | hsa-miR-320a-3p | Alzheimer disease | MNDR-E-MI-39307 |
MNDR | hsa-miR-320a-3p | Sickle cell anemia | MNDR-E-MI-39308 |
MNDR | hsa-miR-320a-3p | Ataxia telangiectasia | MNDR-E-MI-39309 |
MNDR | hsa-miR-320a-3p | Lung cancer | MNDR-E-MI-39310 |
MNDR | hsa-miR-320a-3p | Parkinson disease | MNDR-E-MI-39311 |
MNDR | hsa-miR-320a-3p | Breast cancer | MNDR-E-MI-39312 |
MNDR | hsa-miR-320a-3p | Pituitary neoplasms | MNDR-E-MI-39313 |
MNDR | hsa-miR-320a-3p | Pancreatic cancer | MNDR-E-MI-39314 |
MNDR | hsa-miR-320a-3p | Melanoma | MNDR-E-MI-39315 |
MNDR | hsa-miR-320a-3p | Wilms tumor | MNDR-E-MI-39316 |
MNDR | hsa-miR-320a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-39317 |
MNDR | hsa-miR-320a-3p | Ovarian neoplasms | MNDR-E-MI-39318 |
MNDR | hsa-miR-320a-3p | Kidney cancer | MNDR-E-MI-39319 |
MNDR | hsa-miR-320a-3p | Glioblastoma | MNDR-E-MI-39320 |
MNDR | hsa-miR-320a-3p | Astrocytoma | MNDR-E-MI-39321 |
MNDR | hsa-miR-320a-3p | Glioma | MNDR-E-MI-39322 |
MNDR | hsa-miR-320a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-39323 |
MNDR | hsa-miR-320a-3p | Osteosarcoma | MNDR-E-MI-39324 |
MNDR | hsa-miR-320a-3p | Inclusion body myositis | MNDR-E-MI-39325 |
MNDR | hsa-miR-320a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-39326 |
MNDR | hsa-miR-320a-3p | Uterus cancer | MNDR-E-MI-39327 |
MNDR | hsa-miR-320a-3p | Pituitary adenoma | MNDR-E-MI-39328 |
MNDR | hsa-miR-320a-3p | Lung squamous cell carcinoma | MNDR-E-MI-39329 |
MNDR | hsa-miR-320a-3p | Non-small cell lung cancer | MNDR-E-MI-39330 |
MNDR | hsa-miR-320a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-39331 |
MNDR | hsa-miR-320a-3p | Cholangiocarcinoma | MNDR-E-MI-39332 |
MNDR | hsa-miR-320a-3p | Esophageal cancer | MNDR-E-MI-39333 |
MNDR | hsa-miR-320a-3p | Encephalopathy bovine spongiform | MNDR-E-MI-39334 |
MNDR | hsa-miR-320a-3p | Heart failure | MNDR-E-MI-39335 |
MNDR | hsa-miR-320a-3p | Growth hormone-secreting pituitary adenoma | MNDR-E-MI-39336 |
MNDR | hsa-miR-320a-3p | Encephalomyelitis | MNDR-E-MI-39337 |
MNDR | hsa-miR-320a-3p | Leukoencephalopathy progressive multifocal | MNDR-E-MI-39338 |
MNDR | hsa-miR-320a-3p | Hepatocellular carcinoma | MNDR-E-MI-39339 |
MNDR | hsa-miR-320a-3p | B-cell lymphoma | MNDR-E-MI-39340 |
MNDR | hsa-miR-320a-3p | Malignant pleural mesothelioma | MNDR-E-MI-39341 |
MNDR | hsa-miR-320a-3p | Retinoblastoma | MNDR-E-MI-39342 |
MNDR | hsa-miR-320a-3p | Neuroblastoma | MNDR-E-MI-39343 |
MNDR | hsa-miR-320a-3p | Burkitt lymphoma | MNDR-E-MI-39344 |
MNDR | hsa-miR-320a-3p | Acute myeloid leukemia | MNDR-E-MI-39345 |
MNDR | hsa-miR-320a-3p | Colorectal cancer | MNDR-E-MI-39346 |
MNDR | hsa-miR-320a-3p | Multiple myeloma | MNDR-E-MI-39347 |
MNDR | hsa-miR-320a-3p | Acute lymphocytic leukemia | MNDR-E-MI-39348 |
MNDR | hsa-miR-320a-3p | Nasopharyngeal cancer | MNDR-E-MI-39349 |
MNDR | hsa-miR-320a-3p | Nerve degeneration | MNDR-E-MI-39350 |
MNDR | hsa-miR-320a-3p | Prostatic neoplasms | MNDR-E-MI-39351 |
MNDR | hsa-miR-320a-3p | Reperfusion injury | MNDR-E-MI-39352 |
MNDR | hsa-miR-320a-3p | Chronic pain | MNDR-E-MI-39353 |
MNDR | hsa-miR-320a-3p | Barrett's carcinogenesis | MNDR-E-MI-39354 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCG2 | Homo sapiens | RR00024747 |
TOP